Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Next/Generation Psychedelics

Recent news which mentions Next/Generation Psychedelics

Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
Tickers ENVB
Tags Psychedelics Management Next/Generation Psychedelics
From Benzinga
Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder
Tickers NEWS
Tags Biotech Psychedelics Gilgamesh Pharmaceuticals
From Benzinga
Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
Tickers CYBN
Tags Markets Deuterated Psychedelics News
From Benzinga
Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice
Tickers CMND
Tags Market News Cannabis Psychedelic/Assisted Therapies
From Benzinga
Enveric Biosciences' Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials
Tickers ENVB
Tags Penny Stocks financial results Benzinga
From Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
Tickers ATAI CMPS
Tags Cannabis Markets Market News
From Benzinga
Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic
Tickers MSSTF
Tags Postpartum Depression Guidance Markets
From Benzinga
Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program
Tickers CMND
Tags Markets Guidance News
From Benzinga
Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions
Tickers CYBN DMTTF MSSTF NUGL
Tags Otsuka Pharmaceutical Co Psychedelics Next/Generation Psychedelics
From Benzinga
Boosting Next-Gen Mental Health Care: Enveric's New US Patent For Anxiety Treatment
Tickers ENVB
Tags Benzinga Penny Stocks Psychedelic/Assisted Therapies
From Benzinga
Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library
Tickers CYBN
Tags Psychedelics Next/Generation Psychedelics Benzinga
From Benzinga
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
Tickers ENVB
Tags News Earnings Management
From Benzinga
Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound
Tickers DRUG
Tags Cannabis Market News Benzinga
From Benzinga
Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
Tickers REUN
Tags Psychedelics private development Next/Generation Psychedelics
From Benzinga
Terran Biosciences Steps Into 4-OH-DiPT Prodrug Arena With New Patent Application
Tickers MSSTF REUN
Tags MSSTF News REUN
From Benzinga
Reunion Neuroscience On The Brink Of Going Private With Final Court Approval
Tickers FTHWF MSSTF REUN
Tags Next/Generation Psychedelics Psychedelics FTHWF
From Benzinga
Pioneering Psychedelics Scientist Alexander "Sasha" Shulgin's Legacy Lives On Via New Compounds And Research
Tags Next/Generation Psychedelics Psychedelics the Alexander Shulgin Research Institute Inc/
From Benzinga
This Biotech Is Entering The Clinical Stage With A Psilocin Analog Targeting Cluster Headaches
Tickers LOBEF
Tags Next/Generation Psychedelics LOBEF Psychedelics
From Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
Tickers BETRF PHRRF
Tags Guidance Markets BETRF
From Benzinga
Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor
Tickers CYBN
Tags CYBN Management Earnings
From Benzinga
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
Tickers MSSTF
Tags MSSTF News Legal
From Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
Tickers PMBHF
Tags Markets Guidance PMBHF
From Benzinga
Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update
Tickers MYCOF
Tags News Share Offering Psychedelics
From Benzinga
This Company's Psilocybin-Based Non Hallucinogenic Compound Heads Toward Clinical Studies
Tags Psychedelic/Assisted Therapies psilocybin therapies Benzinga
From Benzinga
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
Tickers HUGE
Tags News HUGE Psychedelics
From Benzinga
Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial
Tags Delix Therapeutics Cannabis Markets
From Benzinga
NY Biotech Gets International IP Coverage For Growing Portfolio Of Psychedelic-Derived Novel Drugs
Tags Market News Cannabis Markets
From Benzinga
This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection
Tickers MSSTF
Tags Market News Cannabis Penny Stocks
From Benzinga
Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds
Tickers DRUG SILO
Tags Next/Generation Psychedelics Psychedelics DRUG
From Benzinga
Are Next-Gen Psychedelics The Incoming Solution For Mental Health? Learn It All At Benzinga's Psychedelics Capital Conference
Tags Markets News General
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.